GPA33: A Marker to Identify Stable Human Regulatory T Cells
- 15 June 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 204 (12) , 3139-3148
Abstract
FOXP3-expressing regulatory T (Treg) cells safeguard immunological tolerance. Treg cells can be generated during thymic development (called thymic Treg [tTreg] cells) or derived from mature conventional CD4+ T cells that underwent TGF-β–mediated conversion in the periphery (called peripheral Treg [pTreg] cells). Murine studies have shown that tTreg cells exhibit strong lineage fidelity, whereas pTreg cells can revert into conventional CD4+ T cells. Their stronger lineage commitment makes tTreg cells the safest cells to use in adoptive cell therapy, increasingly used to treat autoimmune and inflammatory disorders. Markers to distinguish human tTreg cells from pTreg cells have, however, not been found. Based on combined proteomic and transcriptomic approaches, we report that the Ig superfamily protein GPA33 is expressed on a subset of human Treg cells. GPA33 is acquired late during tTreg cell development but is not expressed on TGF-β–induced Treg cells. GPA33 identifies Treg cells in human blood that lack the ability to produce effector cytokines (IL-2, IFN-γ, IL-17), regardless of differentiation stage. GPA33high Treg cells universally express the transcription factor Helios that preferentially marks tTreg cells and can robustly and stably be expanded in vitro even without rapamycin. Expanded GPA33high Treg cells are suppressive, unable to produce proinflammatory cytokines, and exhibit the epigenetic modifications of the FOXP3 gene enhancer CNS2, necessary for indelible expression of this critical transcription factor. Our findings thus suggest that GPA33 identifies human tTreg cells and provide a strategy to isolate such cells for safer and more efficacious adoptive cell therapy. Key Points Thymic-derived Tregs are the most attractive cell type for adoptive cell therapy. Tregs that express the surface marker GPA33 can stably be expanded with high purity. Developing Tregs become GPA33+ around thymic exit, but TGF-β–induced Tregs are GPA33−.Keywords
This publication has 87 references indexed in Scilit:
- CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL‐17 in a STAT3‐dependent mannerEuropean Journal of Immunology, 2013
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- Peripheral education of the immune system by colonic commensal microbiotaNature, 2011
- A Requisite Role for Induced Regulatory T Cells in Tolerance Based on Expanding Antigen Receptor DiversityImmunity, 2011
- Global quantification of mammalian gene expression controlNature, 2011
- Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritisProceedings of the National Academy of Sciences, 2009
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivoNature Immunology, 2009
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Human memory FOXP3+Tregs secrete IL-17 ex vivo and constitutively express the TH17 lineage-specific transcription factor RORγtProceedings of the National Academy of Sciences, 2009
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007